Human Mcl-1/Bcl2L3 quantitates human Mcl-1/Bcl2L3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Mcl-1/Bcl2L3.
Human Mcl-1/Bcl2L3 quantitates human Mcl-1/Bcl2L3 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Mcl-1/Bcl2L3.
MCL1 (myeloid cell leukemia-1) belongs to the Bcl-2 family and is involved in programming, differentiation and concomitant maintenance of cell viability, but not proliferation. The MCL1 isoform 1 inhibits apoptosis while isoform 2 favours it. The carboxylic ends of MCL1 and bcl-2 share a significant sequence homology. MCL-1 expression increases with exposure of ML-1 cells to various types of agents damaging the DNA (e.g. ionizing radiation, ultraviolet radiation, and alcoylants), which is accompanied by increases in GADD45 and Bax and a decrease in bcl-2. Improved MCL-1 expression, mainly associated with mitochondria, completes continuous bcl-2 expression in differentiated ML-1 cells. Like bcl-2, MCL1 has the ability to promote cell viability under conditions that otherwise lead to apoptosis. Although the mechanism by which MCL1 inhibits apoptosis is not known, it is believed that it can heterodimerize and neutralize the pro-apoptotic members of the Bcl-2 family such as Bim or Bak. MCL1 was originally identified in myeloid cell differentiation, but has since been shown to be expressed in several cell types. MCL1 is essential for embryogenesis and for the development and maintenance of B and T lymphocytes in animals. MCL1 exists as at least two distinct isoforms, MCL1L and MCL1S. Unlike the largest MCL1 isoform, overexpression of MCL1S promotes cell death.
Sensitivity
Sensitivity of dosage: 0.13 ng/ml.
Measurement range
Dose range: 0.13 to 25 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; serum, 50 µl; plasma, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17154613 |
| Specifications |
| Accession number | AW556805; D-Apoptosis regulator of the BCL2 family; BCL2L3; bcl2-L-3; protein similar to Bcl-2-3; protein bound to Bcl-2 EAT/mcl1; EAT; Mcl-1 induced myeloid leukaemia cell differentiation protein; Mcl-1 homologous of myeloid leukaemia cell differentiation protein |
| Dose range | 0.13 to 25 ng/ml |
| Sensitivity of the dosage | 0.13 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | Q07820 |
| Gene symbol(s) | MCL1 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | Use exclusively for research |
| Target | MCL-1 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Supernatant, 50 µl; serum, 50 µl; plasma, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH317RB |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.